Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 65/100

Failure Rate

25.0%

1 terminated/withdrawn out of 4 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

25%

1 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
3(75.0%)
Phase 3
1(25.0%)
4Total
N/A(3)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT04612140Not ApplicableCompleted

STereotactic Ablative Radiosurgery of Recurrent Ventricular Tachycardia in Structural Heart Disease

Role: collaborator

NCT04011800Phase 3Unknown

PRAGUE-25 Trial. Catheter Ablation vs. AADs and Risk Factor Modification.

Role: collaborator

NCT03601832Not ApplicableCompleted

Non-invasive Ablation of Ventricular Tachycardia

Role: collaborator

NCT03819504Not ApplicableWithdrawn

Stereotactic Non-invasive Ablation of Ventricular Tachycardia

Role: collaborator

All 4 trials loaded